1家供應(yīng)商在售
|
||||||
商品名稱 | 規(guī)格 | 代理級別 | 價(jià)格 | 運(yùn)費(fèi) | 供應(yīng)商 | 購買 |
CYFIP1 (E6X1U) Rabbit mAb
交貨周期:現(xiàn)貨
|
100 μl | 經(jīng)銷 |
登錄可見
|
- |
北京敏泰元科技有限公司 |
庫存:20
|
REACTIVITY | H M R |
SENSITIVITY | Endogenous |
MW (kDa) | 145 |
Source/Isotype | Rabbit IgG |
Application | Dilution |
---|---|
Western Blotting | 1:1000 |
Immunoprecipitation | 1:50 |
Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 μg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.
CYFIP1 (E6X1U) Rabbit mAb recognizes endogenous levels of total CYFIP1 protein.
Human, Mouse, Rat
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro527 of human CYFIP1 protein.
Cytoplasmic FMR1-interacting protein 1 (CYFIP1) is a component of the CYFIP1/EIF4E/FMR1 complex which mediates translational repression by binding to the mRNA cap (1). CYFIP1 also plays a role in neuronal axonal growth dynamics by binding to the WAVE complex to regulate remodeling of actin filaments (2). Mutations in the gene encoding CYFIP1 has been linked to multiple neural development and psychiatric disorders, including autism spectrum disorder and schizophrenia (3-6). The specific mechanism by which CYFIP1, which is enriched in synapses, contributes to these neurological diseases is unknown, but may involve regulating the balance of synaptic excitation and inhibition to maintain neuronal circuit homeostasis during development and in mature brains (7).
商城介紹 | 媒體報(bào)道 | 法規(guī)政策 | 協(xié)議專區(qū)
京公網(wǎng)安備 11010802025067號 增值電信業(yè)務(wù)經(jīng)營許可證:京B2-20171454 ICP備案號:京ICP備16050672號-1
喀斯瑪科技版權(quán)所有 2017-
藥品醫(yī)療器械網(wǎng)絡(luò)信息服務(wù)備案: (京)-網(wǎng)藥械信息備字(2022)第00393號
醫(yī)療器械網(wǎng)絡(luò)交易服務(wù)第三方平臺備案編號:京網(wǎng)械平臺備字(2021)第00006號
網(wǎng)絡(luò)食品交易第三方平臺提供者備案 :京食藥網(wǎng)食備202110062 信息系統(tǒng)安全等級保護(hù)備案證明(三級)